Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Cassava Sciences | 1,231 | 2021 | |||||||||
Allakos | 121 | 2023q3 | |||||||||
BioLineRx | 2,070 | 2021 | |||||||||
NanoViricides | 17 | 2022q2 | |||||||||
Vor Biopharma | 131 | 2023q3 | |||||||||
BioAtla | 116 | 2023q3 | |||||||||
Lithium Americas | 627 | 2022 | |||||||||
Galera Therapeutics | 1 | 2021 | |||||||||
Ocugen | 299 | 2022 | |||||||||
Canoo | 98 | 2021 | |||||||||
Jaguar Health | 16 | 2022 | |||||||||
Π‘Π΅Π±ΡΡΠΊΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Ρ | 0 | 2023 | |||||||||
Atea Pharmaceuticals | 292 | 2023q3 | |||||||||
Passage Bio | 63 | 2023q3 | |||||||||
Citius Pharmaceuticals | 65 | 2023q3 | |||||||||
Beam Global | 56 | 2022 | |||||||||
Vivani Medical | 64 | 2021 | |||||||||
Quince Therapeutics | 24 | 2021 | |||||||||
Iovance Biotherapeutics | 2,756 | 2023q1 | |||||||||
Gossamer Bio | 130 | 2023q1 |